Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Six scientists from the University of Rochester School of Medicine and Dentistry have been recommended awards of more than $3.5 million by NYSTEM. The grants are for a wide range of research programs in the fields of neurological disorders, bone growth and repair, and cancer.
3/26/2014 | 0 comments
Millions of cancer survivors are dealing with painful neuropathy or hearing loss as a result of chemotherapy, but genomics offers scientists a new opportunity to help them, according to a commentary published in the Journal of National Cancer Institute from a group led by Lois B. Travis, M.D.
3/18/2014 | 0 comments
A new study appearing in Nature Medicine points to a simple blood test that can predict who is at risk of developing Alzheimer’s disease before the symptoms of the disease appear. With this new tool, scientists may be able to develop a new generation of therapies that can head off the disease.
3/10/2014 | 0 comments
A new study found that the presence of complications following surgery is a strong indicator of which patients are likely to be readmitted to the hospital in the 30 days following their procedure.
3/7/2014 | 0 comments
Rochester scientists are using a gene test to diagnose a difficult-to-detect form of bone marrow cancer – an example of how academic medical centers are applying new technology in ways that play to their strengths to achieve better patient care.
3/5/2014 | 0 comments